These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 379222)
21. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. Davignon D; Martz E; Reynolds T; Kürzinger K; Springer TA J Immunol; 1981 Aug; 127(2):590-5. PubMed ID: 6166678 [No Abstract] [Full Text] [Related]
22. The role of immunoglobulin receptors and T cell mediators in B lymphocyte activation. I. B cell activation by anti-immunoglobulin and anti-idiotype reagents. Primi D; Lewis GK; Goodman JW J Immunol; 1980 Sep; 125(3):1286-92. PubMed ID: 6774015 [TBL] [Abstract][Full Text] [Related]
23. Suppression with anti-Ig of immunoglobulin secretion by pig lymphoblasts. Symons DB; Clarkson CA Immunology; 1983 Jul; 49(3):491-9. PubMed ID: 6602759 [TBL] [Abstract][Full Text] [Related]
24. Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation. Boswell HS; Ahmed A; Scher I; Singer A J Immunol; 1980 Sep; 125(3):1340-8. PubMed ID: 6157725 [No Abstract] [Full Text] [Related]
25. Heavy chain isotype suppression: a review of the immunosuppressive effects of heterologous anti-Ig heavy chain antisera. Manning DD J Reticuloendothel Soc; 1975 Jul; 18(1):63-86. PubMed ID: 807728 [No Abstract] [Full Text] [Related]
26. [Surface immunoglobulins]. Janusz M Postepy Hig Med Dosw; 1982; 36(5-6):317-44. PubMed ID: 6764945 [No Abstract] [Full Text] [Related]
27. Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Andersson J; Bullock WW; Melchers F Eur J Immunol; 1974 Nov; 4(11):715-22. PubMed ID: 4214706 [No Abstract] [Full Text] [Related]
28. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell. Klimpel GR; Okada M; Henney CS J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233 [No Abstract] [Full Text] [Related]
29. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation. Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817 [TBL] [Abstract][Full Text] [Related]
30. [Detection of a distinctive differentiating antigen of activated mouse T- and B-lymphocytes--AKA-1]. Nesterenko VG; Novikova TK; Fontalin LN; Vekhnik E; Rubakova EI Biull Eksp Biol Med; 1980 Oct; 90(10):449-51. PubMed ID: 6968597 [TBL] [Abstract][Full Text] [Related]
31. Augmentation of antibody-dependent cell-mediated cytotoxicity by anti-immunoglobulin. II. Mechanism. Stylianos SK; Halloran PF Transplant Proc; 1981 Mar; 13(1 Pt 2):1175-7. PubMed ID: 6973860 [No Abstract] [Full Text] [Related]
32. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3). Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596 [TBL] [Abstract][Full Text] [Related]
33. Separable helper factors support B cell proliferation and maturation to Ig secretion. Parker DC J Immunol; 1982 Aug; 129(2):469-74. PubMed ID: 6806371 [TBL] [Abstract][Full Text] [Related]
34. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
35. Clonal assay for T helper cells (TH) and conditions for H-2-restricted linked cooperation between TH and hapten-primed B cells: application to the quantitation of hemocyanin or Leishmania tropica-specific TH in primed mice. Zubler RH; Louis JA J Immunol; 1981 Nov; 127(5):1924-30. PubMed ID: 7028867 [No Abstract] [Full Text] [Related]
36. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate. Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795 [TBL] [Abstract][Full Text] [Related]
37. The use of haptenated immunoglobulins to induce B cell tolerance in vitro. The roles of hapten density and the Fc portion of the immunoglobulin carrier. Waldschmidt TJ; Borel Y; Vitetta ES J Immunol; 1983 Nov; 131(5):2204-9. PubMed ID: 6226736 [TBL] [Abstract][Full Text] [Related]
38. Splenic B cells from CBA/N mice acquire responsiveness to anti-immunoglobulin after a brief treatment with pronase. Ramanadham M; Gollapudi SV; Kern M J Immunol; 1985 Jan; 134(1):4-6. PubMed ID: 3871111 [TBL] [Abstract][Full Text] [Related]
39. High anti-TNP plaque-forming cell potential of residual mIg+ cells in a T cell population. Mond JJ; Mage MG; Rothstein TL; Mosier DE; Herrod H; Asofsky R; Paul WE J Immunol; 1980 Oct; 125(4):1526-9. PubMed ID: 6774022 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of human B cell-activating factor. I. Comparison of the plaque-stimulating activity with thymocyte-stimulating activity. Wood DD J Immunol; 1979 Nov; 123(5):2400-7. PubMed ID: 158617 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]